Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 3/20 | 0.75 |
| ▸ | CTSS | P25774 | 3/20 | 0.75 |
| ▸ | CTSB | P07858 | 2/20 | 0.75 |
| ▸ | MEN1 | O00255 | 2/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.69 |
| ▸ | LMNA | P02545 | 1/20 | 0.69 |
| ▸ | CTSK | P43235 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | CASP3 | P42574 | 2/20 | 0.57 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.55 |
| ▸ | CAPN2 | P17655 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | CA5A | P35218 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | SIRT2 | Q8IXJ6 | 4/20 | 0.52 |
| ▸ | SIRT1 | Q96EB6 | 3/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2402826 | 1.00 | CTSL (0.75) | CTSLCTSSCTSBMEN1KMT2A | |
| SCHEMBL10070321 | 1.00 | CTSL (0.75) | CTSLCTSSCTSBMEN1KMT2A | |
| SCHEMBL2445899 | 1.00 | CTSL (0.75) | CTSLCTSSCTSBMEN1KMT2A | |
| SCHEMBL13610343 | 1.00 | CTSL (0.75) | CTSLCTSSCTSBMEN1KMT2A | |
| SCHEMBL2442047 | 1.00 | CTSL (0.75) | CTSLCTSSCTSBMEN1KMT2A | |
| SCHEMBL2445911 | 1.00 | CTSL (0.75) | CTSLCTSSCTSBMEN1KMT2A | |
| SCHEMBL2448660 | 1.00 | CTSL (0.75) | CTSLCTSSCTSBMEN1KMT2A | |
| SCHEMBL2445913 | 1.00 | CTSL (0.75) | CTSLCTSSCTSBMEN1KMT2A | |
| SCHEMBL17965152 | 1.00 | CTSL (0.75) | CTSLCTSSCTSBMEN1KMT2A | |
| SCHEMBL13589409 | 1.00 | CTSL (0.75) | CTSLCTSSCTSBMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2365050-B1 | DI-AMIDO GELLANT FOR USE IN CONSUMER PRODUCT COMPOSITIONS | PROCTER & GAMBLE (US) | 2016-08-10 | — | — | EP | claimed |
| US-8207107-B2 | Di-amido gellant for use in consumer product compositions | THE PROCTER & GAMBLE COMPANY (US) | 2012-06-26 | — | — | US | claimed |
| US-20110224455-A1 | Di-Amido Gellant For Use In Consumer Product Compositions | THE PROCTER & GAMBLE COMPANY | 2011-09-15 | — | — | US | claimed |
| EP-2365050-A1 | Di-amido gelaant for use in consumer product compositions | The Procter & Gamble Company (US) | 2011-09-14 | — | — | EP | claimed |
| EP-2365050-B1 | DI-AMIDO GELLANT FOR USE IN CONSUMER PRODUCT COMPOSITIONS | PROCTER & GAMBLE (US) | 2016-08-10 | — | — | EP | disclosed |
| EP-2365050-A1 | Di-amido gelaant for use in consumer product compositions | The Procter & Gamble Company (US) | 2011-09-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224455-A1 | Di-Amido Gellant For Use In Consumer Product Compositions | DAGLA, GNPAT, CDIPT | CTSL 4507/4885CTSS 4321/4885CTSB 3509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.